Key malaria chemoprevention highlights at 2025 ASTMH

It’s a wrap! The 2025 ASTMH Annual Meeting once again brought together nearly 5,000 global health professionals from academia, foundations, government, not-for-profit and non-governmental organisations, as well as the private sector for a five-day programme, featuring some of the most important emerging research and evidence in the fields of tropical medicine, hygiene and global health.

This year’s key malaria chemoprevention agenda included four strong line-up of seasonal malaria chemoprevention (SMC) and perennial malaria chemoprevention (PMC)-focused scientific symposia, more than a dozen oral presentations and over 100 posters, covering topics ranging from impact and effectiveness of SMC, optimising SMC delivery through digital micro-planning, real-world impact evaluations, expanding chemoprevention to school-aged children, to new findings on sulfadoxine-pyrimethamine (SP) resistance markers and post-discharge malaria chemoprevention.

Several sessions also featured early results from malaria vaccine uptake and large-scale PMC implementation across multiple countries.

The Annual Meeting provided an important platform for knowledge exchange and collaboration, alongside dedicated SMC Alliance subgroup meetings on monitoring and evaluation, advocacy and communications, and research. Taken together, these events reflected the growing momentum behind chemoprevention research and policy, and the continued leadership of national malaria programmes and Alliance partners in advancing this agenda.